Kevin McCully, a professor of kinesiology in the College of Education, received $263,348 from Biogen Idec, Inc., a biotechnology firm that develops new therapies for neurodegenerative diseases. McCully will measure oxygen delivery and metabolism in the skeletal muscles of people with Lou Gehrig’s disease in comparison to healthy individuals.
